Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer

British Journal of Surgery

Volumn 97, Issue 8, 2010, Pages 1260-1268

  Yokoyama, Y ^a   Nishio, H ^a   Ebata, T ^a   Igami, T ^a   Sugawara, G ^a   Nagino, M ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT; INDOCYANINE GREEN;

ACUTE LIVER FAILURE; ADULT; AGED; ARTICLE; BILIARY TRACT TUMOR; DECOMPRESSION SURGERY; EVALUATION; FEMALE; HUMAN; LIVER RESECTION; MALE; MIDDLE AGED; MORTALITY; OBSTRUCTIVE JAUNDICE; ORGAN SIZE; PATHOPHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BILIARY TRACT NEOPLASMS; COLORING AGENTS; DECOMPRESSION, SURGICAL; FEMALE; HEPATECTOMY; HUMANS; INDOCYANINE GREEN; JAUNDICE, OBSTRUCTIVE; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; ORGAN SIZE; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 77955183468     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7084     Document Type: Article

References (32)

1. Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N et al. Complications of hepatectomy for hilar cholangiocarcinoma. World J Surg 2001; 25: 1277-1283.
2. FazakasJ, Mándli T, Ther G, Arkossy M, Pap S, Fuie B et al. Evaluation of liver function for hepatic resection. Transplant Proc 2006; 38: 798-800.
3. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa. K. et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26: 1176-1181.
4. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 1992; 163: 515-518.
5. Kadono J, Kumemura. H, Nishida. S, Nakamura N, Gejima K, Nakajo M et al. 99mTc-DTPA-galactosylhuman-serum-albumin liver scintigraphy for evaluating hepatic functional reserve before hepatectomy in a patient with indocyanine green excretory defect: report of a case. Surg Today 2006; 36: 481-484.
6. Kokudo N, Vera. DR, Tada K, Koizumi M, Seki M, Matsubara T et al. Predictors of successful, hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg 2002; 26: 1342-1347.
7. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 2006; 243: 364-372.
8. Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 2000; 232: 786-795.
9. Dimick JB, Pronovost PJ, Cowan JA Jr, Lipsett PA. Postoperative complication rates after hepatic resection in Maryland hospitals. Arch Sarg 2003; 138: 41-46.
10. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y et al. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 1995; 21:434-439.
11. Nagino M, Kamiya J, Kanai M, Uesaka K, Sano T, Yamamoto H et al. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery 2000; 127: 155-160.
12. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
13. Nimura. Y, Kamiya J, Kondo S, Nagino M, Uesaka K, Oda K et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 2000; 7: 155-162.
14. Nagino M, Kanai M, Morioka A, Yamamoto H, Kawabata Y, Hayakawa N et al. Portal and arterial embolization before extensive liver resection in patients with markedly poor functional reserve. J Vasc Interv Radiol 2000; 11: 1063-1068.
15. Gruttadauria S, Luca A, Mandalà L, Miraglia R, Gridelli B. Sequential preoperative ipsilateral portal and arterial embolization in patients with colorectal liver metastases. World J Surg 2006; 30: 576-578.
16. Kyokane T, Nagino M, Oda. K, Nimura. Y. An experimental study of selective intrahepatic biliary ablation with ethanol. J Surg Res 2001; 96: 188-196.
17. Sawada T, Kita J, Nagata. H, Shimoda. M, Kubota. K. Hepatectomy for metastatic liver tumor in patients with liver dysfunction. Hepatogastroenterology 2007; 54: 2306-2309.
18. Ferrero A, Viganò L, Polastri R, Muratore A, Eminefendic H, Regge D et al. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg 2007'; 31: 1643-1651.
19. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ; Edinburgh Liver Surgery and Transplantation Experimental Research Group (eLISTER). The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289-296.
20. Kaneko K, Shirai Y, Wakai T, Yokoyama N, Akazawa K, Hatakeyama. K. Low preoperative platelet counts predict a. high mortality after partial hepatectomy in patients with hepatocellular carcinoma. World J Gastroenterol 2005; 11: 5888-5892.
21. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S et al. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 2002; 236: 397-406.
22. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240: 698-708.
23. Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008;247: 118-124.
24. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg 1995; 169: 589-594.
25. Kanematsu T, Furui J, Yanaga K, Okudaira. S, Kamohara. Y, Eguchi S. Measurement of portal venous pressure is useful for selecting the optimal type of resection in cirrhotic patients with hepatocellular carcinoma.. Hepatogastroenterology 2005;52:1828-1831.
26. Sano T, Shimada K, Sakamoto Y, Esaki M, Kosuge T. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years. J Hepatobiliary Pancreat Surg 2007; 14: 455-462.
27. Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 2004; 240: 95-101.
28. Cheng Q, Luo X, Zhang B, Jiang X, Yi B, Wu M. Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival. Eur J Surg Oncol 2007; 33: 202-207.
29. Nagino M, Kamiya J, Arai T, Nishio H, Ebata T, Nimura. Y. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery 2005; 137: 148-155.
30. Kanazawa H, Nagino M, Kamiya S, Komatsu S, Mayumi T, Takagi K et al. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 2005; 390: 104-113.
31. Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 2006; 244: 706-714.
32. Maeda H, Okabayashi T, Kobayashi M, Sugimoto T, Namikawa T, Okamoto K et al. Hepatectomy for hepatocellular carcinoma with indocyanine green excretory defect: a case report. Hepatogastroenterology 2007; 54: 1810-1812.